Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
****nal
i cannot find relevant puretech mention in tipranks.
anything of interest
Ars,
Hopefully Puretech will RNS this information later today when US markets open
Cheers
Joshing
Well my response to you is that if a Liquidator is appointed or a massive discounted placing is in the offing, then Lisa's reply and comments would be totally egregious and misleading in the extreme so my point is that the horror scenarios speculated on by some posters here are supported by her response to me.
Having said that I have been totally fooled and shafted by other AIM companies Investor Relations correspondence in the past but for now I trust Lisa Badderoon.
I have received a reply to my email from Lisa the full details I will not go into but I would advise any genuine investors here to contact Lisa and she will respond if you are on the shareholders register.
The only comments I would make is that Lisa referred to the detailed update issued by the company last December and to the current collapse in a host of AIM Biotech companies which , like Immupharma, bear no relation in many cases to the valuation of the assets in these companies.
Finally she said the Board will look to issue further updates in the near future and as the Directors are shareholders themselves , they are committed to increasing the value of the company's shares to reflect the true value of its assets.
I hope that is some assistance to genuine investors here as I trust Lisa and her integrity.
ATB
Lambo is quite correct in saying Immupharma will not be able to raise any funds via a share issue with SP heading to .5p so it will have to pull a large rabbit out of the hat somehow.
I have emailed Lisa regarding the collapse in the SP today and said it is disgraceful that shareholders are kept in the dark as we lose all our investment.
Moneymore
Immupharma has used part of the £62m losses in obtaining R&D Tax Credit relief but a major element of the losses remain untouched ( strangely I think the unused amount may be nearer £50m , a figure quoted by Alex who appears to know an awful lot about Immupharma..I wonder???)
Pokerchips
The figure for accumulated losses forward for possible set off of tax liabilities against future profits are a scary £62m as at the end of June 2023.
If a profitable acquirer was to take over Immupharma and merge its business, it would have a significant tax shield derived from Immupharma's losses forward.